Skip to content

The Efficacy and Safety of Robotic Bronchoscopy System-Assisted Stent Placement in Patients with Malignant Central Airway Stenosis

A Prospective Multicenter Single-Arm Trial Evaluating the Efficacy and Safety of Robotic Bronchoscopy System-Assisted Stent Placement in Patients with Malignant Central Airway Stenosis

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06832943
Enrollment
30
Registered
2025-02-18
Start date
2025-02-15
Completion date
2025-12-31
Last updated
2025-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Stenosis

Brief summary

The primary aim of this research is to assess the efficacy and safety of the bronchial navigation positioning equipment in assisting stent implantation for malignant central airway stenosis while guaranteeing the safety of the participants and the scientificity of the clinical trial.

Interventions

PROCEDUREUnicorn system

Patients with airway stenosis undergo stent placement with the help of RBS.

Sponsors

Guangzhou Medical University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients are eligible only if they fulfill all of the following criteria: 1. Age ≥ 18 years, regardless of gender; 2. Patients voluntarily consent to airway stent implantation and meet the requirements for airway stent implantation under general anesthesia; 3. Confirmed as having malignant central airway stenosis through bronchoscopy and being ineligible for surgery or refusing surgery, and in need of airway stent implantation. Patients should be able to understand the purpose of the trial, demonstrate good compliance with the examinations and follow-ups, and voluntarily participate in the clinical trial and sign the informed consent form.

Exclusion criteria

* Patients fulfilling any of the following criteria will be excluded from this study: 1. Severe dysfunction of the heart, lungs, liver, or kidneys, intolerant of bronchoscopic treatment; 2. Apparent coagulation dysfunctions; 3. Pregnant or lactating women, or participants with a pregnancy plan during the study period; 4. Patients with implanted cardiac pacemakers, implanted defibrillators, or other active implants; 5. Participants allergic to photosensitizers or anesthetics, or with a history of multiple severe allergies or hereditary allergies; 6. Participants who have participated in or are currently participating in drug clinical trials within the past 3 months, or in other medical device clinical trials within the past 30 days; Other circumstances that the investigator considers inappropriate for participation in this clinical trial.

Design outcomes

Primary

MeasureTime frameDescription
The success rate of stent placementDuring the bronchoscopyThe success rate of stent placement = (The number of patients with successful stent placement / The number of patients undergoing stent placement surgery) × 100% Successful placement: The stent is placed in the appropriate position without displacement, and the upper and lower ends of the stent are unobstructed.

Contacts

Primary ContactChanghao Zhong
vast1982@126.com020-81566640

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026